SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-18-002374
Filing Date
2018-08-13
Accepted
2018-08-13 07:01:28
Documents
31
Period of Report
2018-08-13

Document Format Files

Seq Description Document Type Size
1 6-K zk1821947.htm 6-K 10066
2 PRESS RELEASE exhibit_1.htm EX-99 287929
3 CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS exhibit_2.htm EX-99 302062
4 OPERATING AND FINANCIAL REVIEW exhibit_3.htm EX-99 194383
11 image0.jpg GRAPHIC 9376
  Complete submission text file 0001178913-18-002374.txt   1757023

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blrx-20180630.xml EX-101.INS 138504
6 XBRL TAXONOMY EXTENSION SCHEMA blrx-20180630.xsd EX-101.SCH 28552
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE blrx-20180630_cal.xml EX-101.CAL 34327
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blrx-20180630_def.xml EX-101.DEF 38892
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE blrx-20180630_lab.xml EX-101.LAB 164530
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blrx-20180630_pre.xml EX-101.PRE 90597
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 181010240
SIC: 2834 Pharmaceutical Preparations